Magazine H I, Malik A B, Bruner C A, Andersen T T
Department of Biochemistry & Molecular Biology, Albany Medical College, New York.
J Pharmacol Exp Ther. 1992 Feb;260(2):632-6.
We examined the relative importance of the two amino groups of endothelin-1 in mediating pulmonary vasoconstrictor activity. Complete acetylation of prefolded endothelin-1 (fAcET-1[AcK9]) yielded a product with vasoconstrictor properties (EC50 = 0.52 +/- 0.04 nM) in isolated Ringer-perfused guinea pig lungs similar to native endothelin-1 (EC50 = 0.31 +/- 0.05 nM). However, fAcET-1[AcK9] exhibited a marked reduction in potency when assessed by contraction of isolated guinea pig pulmonary artery strips or by contraction of carotid artery or aortic strip preparations. fAcET-1[AcK9] at concentrations up to 100 nM failed to induce appreciable contraction of any vascular strip preparation. In contrast, endothelin-1 had an EC50 of 1.46 +/- 0.32 to 1.88 +/- 0.19 nM in various vessel preparations. The differences in response to fAcET-1[AcK9] in the intact lung vs. strip preparation suggest different receptor populations in the two preparations. The importance of specific amino groups for contractile activity in the vascular strip preparation was explored by acetylation of individual sites (amino terminus or lysine sidechain) or both sites during peptide synthesis to produce AcET-1, ET-1[AcK9], and AcET-1[AcK9], respectively. The order of potency was endothelin-1 much greater than ET-1[AcK9] greater than AcET-1 greater than AcET-1[AcK9]. These results suggest that chemical modifications (e.g., biotinylation) should be made preferentially at the lysine-9 sidechain in order to retain maximal biological activity in vascular strip preparations.(ABSTRACT TRUNCATED AT 250 WORDS)
我们研究了内皮素 -1 的两个氨基在介导肺血管收缩活性中的相对重要性。预折叠的内皮素 -1(fAcET -1[AcK9])完全乙酰化后,在分离的经林格氏液灌注的豚鼠肺中产生了一种具有血管收缩特性的产物(EC50 = 0.52±0.04 nM),类似于天然内皮素 -1(EC50 = 0.31±0.05 nM)。然而,当通过分离的豚鼠肺动脉条收缩或颈动脉或主动脉条制剂收缩来评估时,fAcET -1[AcK9]的效力显著降低。浓度高达 100 nM 的 fAcET -1[AcK9]未能诱导任何血管条制剂出现明显收缩。相比之下,内皮素 -1 在各种血管制剂中的 EC50 为 1.46±0.32 至 1.88±0.19 nM。完整肺与条制剂中对 fAcET -1[AcK9]反应的差异表明两种制剂中存在不同的受体群体。通过在肽合成过程中对单个位点(氨基末端或赖氨酸侧链)或两个位点进行乙酰化以分别产生 AcET -1、ET -1[AcK9]和 AcET -1[AcK9],探讨了特定氨基对血管条制剂中收缩活性的重要性。效力顺序为内皮素 -1 远大于 ET -1[AcK9]大于 AcET -1 大于 AcET -1[AcK9]。这些结果表明,为了在血管条制剂中保留最大生物活性,应优先在赖氨酸 -9 侧链进行化学修饰(如生物素化)。(摘要截断于 250 字)